- Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance Investor’s Business Daily
- Moderna cuts 2025 sales forecast by $1 billion on weak vaccine demand, shares fall Yahoo Finance
- JPM25: Moderna slashes guidance, plots $1B in cost cuts this year amid lackluster vaccine sales FiercePharma
- Moderna’s stock tumbles to post-COVID lows after revenue outlook disappoints MarketWatch
- Moderna stock plunges 20% after company lowers 2025 sales forecast by $1 billion CNBC